Pablo Cabello Albendea
Fondateur chez Advanced Marker Discovery SL
Profil
Pablo Cabello Albendea is the founder of Advanced Marker Discovery SL.
He currently holds the position of President at Biocross SL, Raman Health Technologies SL, and Founding Partner at Cross Road Biotech Inversiones Biotecnologicas SGEIC SA. Previously, he served as Chairman & Managing Director at Inversiones Jalabun SICAV SA, Chairman at Venter Pharma SL, Chairman & President at Traslational Cancer Drugs Pharma SL, and Biologist at Consejo Superior de Investigaciones Científicas.
He also served as President at Dendrico SL from 2006 to 2012 and as a Biologist at Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción.
He obtained his undergraduate degree from Universidad Autónoma de Madrid.
Postes actifs de Pablo Cabello Albendea
| Sociétés | Poste | Début |
|---|---|---|
Biocross SL
 Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | President | - |
Raman Health Technologies SL
 Raman Health Technologies SL BiotechnologyHealth Technology Raman Health Technologies SL researches and develops laser and spectroscopy-based diagnostic technology. The company was founded by Perez F. Rull on February 14, 2013 and is headquartered in Boecillo, Spain. | President | - |
Advanced Marker Discovery SL
 Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Fondateur | - |
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
 Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | - |
Anciens postes connus de Pablo Cabello Albendea
| Sociétés | Poste | Fin |
|---|---|---|
Traslational Cancer Drugs Pharma SL
 Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Président | - |
Venter Pharma SL
 Venter Pharma SL Pharmaceuticals: MajorHealth Technology Venter Pharma SL develops and manufactures pharmaceutical products. The firm’s products include lactest and xylossay. The company was founded by Juan Jose Aragon Reyes and Alfonso Fernandez Alvarez Mayoralas in 2003 and is headquartered in Alcobendas, Spain. | Président | - |
Inversiones Jalabun SICAV SA
 Inversiones Jalabun SICAV SA Investment Trusts/Mutual FundsMiscellaneous Inversiones Jalabun SICAV SA is an open-end investment company which primarily invests in equity securities. The company was founded on February 3, 1999 and is headquartered in Madrid, Spain. | Directeur Général | - |
| Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción | Corporate Officer/Principal | - |
| Consejo Superior de Investigaciones Científicas | Corporate Officer/Principal | - |
Formation de Pablo Cabello Albendea
| Universidad Autónoma de Madrid | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Dendrico SL
 Dendrico SL Miscellaneous Commercial ServicesCommercial Services Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain. | Commercial Services |
| Fundación Jiménez Díaz Clínica Nuestra Señora de la Concepción | |
Inversiones Jalabun SICAV SA
Inversiones Jalabun SICAV SA Investment Trusts/Mutual FundsMiscellaneous Inversiones Jalabun SICAV SA is an open-end investment company which primarily invests in equity securities. The company was founded on February 3, 1999 and is headquartered in Madrid, Spain. | Miscellaneous |
Venter Pharma SL
Venter Pharma SL Pharmaceuticals: MajorHealth Technology Venter Pharma SL develops and manufactures pharmaceutical products. The firm’s products include lactest and xylossay. The company was founded by Juan Jose Aragon Reyes and Alfonso Fernandez Alvarez Mayoralas in 2003 and is headquartered in Alcobendas, Spain. | Health Technology |
Biocross SL
Biocross SL Medical SpecialtiesHealth Technology Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain. | Health Technology |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |
Raman Health Technologies SL
Raman Health Technologies SL BiotechnologyHealth Technology Raman Health Technologies SL researches and develops laser and spectroscopy-based diagnostic technology. The company was founded by Perez F. Rull on February 14, 2013 and is headquartered in Boecillo, Spain. | Health Technology |
Advanced Marker Discovery SL
Advanced Marker Discovery SL Medical SpecialtiesHealth Technology Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain. | Health Technology |
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
